DK0615442T3 - Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse. - Google Patents

Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse.

Info

Publication number
DK0615442T3
DK0615442T3 DK92924548.8T DK92924548T DK0615442T3 DK 0615442 T3 DK0615442 T3 DK 0615442T3 DK 92924548 T DK92924548 T DK 92924548T DK 0615442 T3 DK0615442 T3 DK 0615442T3
Authority
DK
Denmark
Prior art keywords
matrix
thermocloid
gelatin
sun
regulated
Prior art date
Application number
DK92924548.8T
Other languages
English (en)
Inventor
Ursula Schick
Juergen Freidenreich
Jens-Christian Wunderlich
Juergen Werry
Original Assignee
Alfatec Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfatec Pharma Gmbh filed Critical Alfatec Pharma Gmbh
Application granted granted Critical
Publication of DK0615442T3 publication Critical patent/DK0615442T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Luminescent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92924548.8T 1991-12-05 1992-12-04 Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse. DK0615442T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4140192A DE4140192C2 (de) 1991-12-05 1991-12-05 Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen

Publications (1)

Publication Number Publication Date
DK0615442T3 true DK0615442T3 (da) 1997-10-20

Family

ID=6446393

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924548.8T DK0615442T3 (da) 1991-12-05 1992-12-04 Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse.

Country Status (9)

Country Link
US (1) US6068854A (da)
EP (1) EP0615442B1 (da)
AT (1) ATE158177T1 (da)
AU (1) AU3080392A (da)
DE (2) DE4140192C2 (da)
DK (1) DK0615442T3 (da)
ES (1) ES2108138T3 (da)
GR (1) GR3025362T3 (da)
WO (1) WO1993010764A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939105B2 (en) 1998-11-20 2011-05-10 Jagotec Ag Process for preparing a rapidly dispersing solid drug dosage form
US6992172B1 (en) * 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
JP2001329183A (ja) * 2000-05-22 2001-11-27 Yuichi Mori ゲル化性組成物
NZ525231A (en) * 2000-09-20 2004-08-27 Skyepharma Canada Inc Phospholipid stabilised feno-fibrate microparticles for pharmaceutical use
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US6569454B2 (en) * 2001-02-27 2003-05-27 Minh Van Nguyen Simple tablet compression using gelatin
AU2003208918A1 (en) * 2003-01-03 2004-08-10 Minh Nguyen Simple tablet compression using gelatin
JP5296314B2 (ja) * 2003-07-17 2013-09-25 バナー ファーマキャップス，インコーポレイティド 制御放出製剤
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
CN104606199B (zh) 2006-03-29 2022-09-13 维斯塔实验室有限公司 3,7-二氨基-10h-吩噻嗪化合物盐及其用途
US20100322978A1 (en) * 2006-12-27 2010-12-23 Fujifilm Corporation Medical composition
EP1961414A1 (en) * 2007-02-21 2008-08-27 FUJIFILM Manufacturing Europe B.V. A controlled release composition comprising a recombinant gelatin
EP1961411A1 (en) * 2007-02-21 2008-08-27 FUJIFILM Manufacturing Europe B.V. A controlled release composition
ATE554103T1 (de) * 2007-02-21 2012-05-15 Fujifilm Mfg Europe Bv Rgd-haltige rekombinante gelatine
DK2205245T3 (da) * 2007-10-03 2015-09-28 Wista Lab Ltd Terapeutisk anvendelse af diaminophenothiaziner
DE102007051059B4 (de) * 2007-10-18 2014-04-03 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Bioverbundmaterial für die kontrollierte Freisetzung von Wirkstoffen
CA2827027C (en) 2011-02-11 2019-06-04 Wista Laboratories Ltd. Phenothiazine diaminium salts and their use
WO2017137992A1 (en) 2016-02-11 2017-08-17 Gelpell Ag Oral solid cannabinoid formulations, methods for producing and using thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2183053A (en) * 1936-12-03 1939-12-12 Atlantic Coast Fisheries Co Vitamin preparation and method of making same
US2756177A (en) * 1953-03-09 1956-07-24 Hoffmann La Roche Process for making fat-soluble vitamin active powder
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
GB1144915A (en) * 1966-11-24 1969-03-12 Armour Pharma Improvements in or relating to pastille formulations
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
AT319191B (de) * 1969-08-01 1974-12-10 Bush Boake Allen Ltd Zweiwandige wasserunlösliche Mikrokapseln zur Abgabe von aromatisierenden Substanzen
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
WO1985005029A1 (en) * 1984-05-09 1985-11-21 Medaphore Inc. Oral insulin and a method of making the same
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
DE3684446D1 (de) * 1985-12-28 1992-04-23 Sumitomo Pharma Arzneimittel mit verzoegerter stossweiser freisetzung.
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
IT1204294B (it) * 1986-03-11 1989-03-01 Gentili Ist Spa Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
SE8705136D0 (sv) * 1987-12-22 1987-12-22 Pharmacia Ab Oral doseringsenhet for lekemedel och dess anvendning och framstellning
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5126151A (en) * 1991-01-24 1992-06-30 Warner-Lambert Company Encapsulation matrix

Also Published As

Publication number Publication date
US6068854A (en) 2000-05-30
ES2108138T3 (es) 1997-12-16
WO1993010764A1 (de) 1993-06-10
GR3025362T3 (en) 1998-02-27
DE4140192A1 (de) 1993-06-09
EP0615442B1 (de) 1997-09-17
EP0615442A1 (de) 1994-09-21
ATE158177T1 (de) 1997-10-15
DE59208919D1 (en) 1997-10-23
AU3080392A (en) 1993-06-28
DE4140192C2 (de) 1996-02-29

Similar Documents

Publication Publication Date Title
GR3025362T3 (en) Sol-controlled gelatine-based thermocolloidal matrix for peroral prolonged action administration forms.
FR2542998B1 (fr) Nouvelle forme transdermale du dinitrate d'isosorbide
EP0374359A3 (en) Chewable, edible soft gelatin capsule
PT86536A (pt) Sistema terapeutico para ingredientes activos pouco soluveis
DE3773468D1 (de) Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung.
NL930008I2 (nl) Carboxyalkyldipeptide-derivaten, werkwijze ter bereiding ervan en farmaceutische samenstelling, die deze bevat.
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
KR870002832A (ko) 제약 조성물
JPS51148013A (en) Stable insulin preparation for nosal administration
ES516375A0 (es) Procedimiento para la obtencion de una composicion a base de estireno para revestir alimentos y medicamentos.
ES513159A0 (es) "procedimiento para la preparacion de polipeptidos inmunogenamente activos y producidos microbianamente, para la obtencion de una vacuna contra la fiebre aftosa".
DE3771091D1 (de) Formulierung mit langsamer freisetzung.
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
JPS5356315A (en) Emulsified solution of fat soluble drugs
ATE68686T1 (de) System zum freigeben von stoffen in der vagina.
JPS5218813A (en) Plasters for the relief of cutaneous diseases
ES8307230A1 (es) "un procedimiento para la preparacion de oxaprocin calcico".
NO891046D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.
JPS51128438A (en) An antibacterial drug against fish diseases
JPS5290615A (en) Water-soluble solid and aqueous solution of n4-acylcytosine arabinosid e
JPS55122724A (en) Antidiabetic agent
NO161917C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av tieno- og furo-(2,3-c)-pyrroler.
NO893768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater.
FI821857A7 (fi) Amidoksiimien heterosykliset johdannaiset, niiden valmistus ja soveltaminen tautien hoitoon.
KR900017599A (ko) 종양 치료용 약학 조성물